Tech Company Financing Transactions

Debut Biotechnology Funding Round

Debut Biotechnology, operating out of San Diego, raised $40 million from L'Oreal BOLD Ventures.

Transaction Overview

Announced On
10/19/2023
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors

L'Oreal BOLD Ventures (Lead Investor)

Proceeds Purpose
The company intends to use the funds to accelerate the development of bio-identical and novel fragrance molecules.

Company Information

Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
6330 Nancy Ridge Dr. 106
San Diego, CA 92121
USA
Email Address
Not Recorded
Overview
Debut Biotechnology is commercializing cell-free biomanufacturing solutions by creating advanced enzyme-based manufacturing processes for high-value molecules. Our platform combines immobilized enzymes with highly controlled and automated continuous manufacturing systems for the pharmaceutical and specialty chemical industries.
Profile
Debut Biotechnology LinkedIn Company Profile
Social Media
Debut Biotechnology Company Twitter Account
Company News
Debut Biotechnology News
Facebook
Debut Biotechnology on Facebook
YouTube
Debut Biotechnology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joshua Britton
  Joshua Britton LinkedIn Profile  Joshua Britton Twitter Account  Joshua Britton News  Joshua Britton on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/19/2023: Gardenuity venture capital transaction
Next: 10/19/2023: Healthcaters venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary